FibroGen (FGEN) Priced

Developing therapies for anemia and fibrosis; backed by Astellas and AstraZeneca

Health Care - Biotechnology

IPO Performance
Latest Trade $25.85 +0.85 (+3.4%)
First Day Return 22.2%
Return from IPO 38.9%
 
FibroGen IPO News more
  • .
IPO Data
IPO File Date 10/01/2014
Offer Price $18.00
Price Range $16.00 - $19.00
Offer Shares (mm) 8.1
Deal Size ($mm) 146
 
IPO Data
IPO Date 11/13/2014
Offer Price $18.00
Price Range $16.00 - $19.00
Offer Shares (mm) 8.1
Deal Size ($mm) $146
 
Underwriters
more
Business Overview
Developing therapies for anemia and fibrosis; backed by Astellas and AstraZeneca
Developing therapies for anemia and fibrosis; backed by Astellas and AstraZeneca
more
Company Data
Headquarters San Francisco, CA
Founded 1993
Employees 337
Website www.FibroGen.com
 

Performance vs. IPO Index (IPOUSA)